See more : E. I. du Pont de Nemours and Company (CTA-PB) Income Statement Analysis – Financial Results
Complete financial analysis of DH Enchantment Inc. (ENMI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of DH Enchantment Inc., a leading company in the Medical – Distribution industry within the Healthcare sector.
- Tong Ren Tang Technologies Co. Ltd. (1666.HK) Income Statement Analysis – Financial Results
- PYX Resources Limited (PYX.L) Income Statement Analysis – Financial Results
- LEVERAGE SHARES PUBLIC LIMITED (1ARW.L) Income Statement Analysis – Financial Results
- CStone Pharmaceuticals (CSPHF) Income Statement Analysis – Financial Results
- Marathon Digital Holdings, Inc. (MARA.MX) Income Statement Analysis – Financial Results
DH Enchantment Inc. (ENMI)
Industry: Medical - Distribution
Sector: Healthcare
About DH Enchantment Inc.
DH Enchantment Inc., through its subsidiary, Ho Shun Yi Limited, engages in the sale and distribution of COVID-19 rapid antigen tester sets in Hong Kong. It primarily serves personal hygiene products distributors. The company was formerly known as Energy Management International, Inc. and changed its name to DH Enchantment Inc. in August 2021. DH Enchantment Inc. was incorporated in 2004 and is based in in Kowloon, Hong Kong.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 686.00 | 15.10K | 548.57K | 211.55K | 0.00 |
| Cost of Revenue | 1.09K | 6.65K | 439.34K | 165.96K | 0.00 |
| Gross Profit | -406.00 | 8.45K | 109.23K | 45.59K | 0.00 |
| Gross Profit Ratio | -59.18% | 55.98% | 19.91% | 21.55% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 144.83K | 158.23K | 317.00K | 36.89K | 0.00 |
| Selling & Marketing | 0.00 | 226.37K | 226.37K | 0.00 | 0.00 |
| SG&A | 144.83K | 384.59K | 543.37K | 36.89K | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 144.83K | 384.59K | 543.37K | 36.89K | 0.00 |
| Cost & Expenses | 145.93K | 391.24K | 982.71K | 202.85K | 0.00 |
| Interest Income | 9.00 | 4.00 | 1.00 | 0.00 | 0.00 |
| Interest Expense | 10.92K | 9.74K | 8.94K | 0.00 | 0.00 |
| Depreciation & Amortization | 9.00 | 376.14K | 434.14K | -8.70K | 206.30K |
| EBITDA | -145.23K | -376.14K | -434.05K | 8.70K | 0.00 |
| EBITDA Ratio | -21,170.55% | -2,491.30% | -79.14% | 4.11% | 0.00% |
| Operating Income | -145.24K | -376.14K | -434.14K | 8.70K | 0.00 |
| Operating Income Ratio | -21,171.87% | -2,491.32% | -79.14% | 4.11% | 0.00% |
| Total Other Income/Expenses | -10.91K | -9.74K | -8.84K | 0.00 | 0.00 |
| Income Before Tax | -156.15K | -385.88K | -442.98K | 8.70K | 0.00 |
| Income Before Tax Ratio | -22,762.83% | -2,555.82% | -80.75% | 4.11% | 0.00% |
| Income Tax Expense | 0.00 | 19.48K | -92.00 | 8.70K | 0.00 |
| Net Income | -156.15K | -385.88K | -442.89K | 8.70K | 0.00 |
| Net Income Ratio | -22,762.83% | -2,555.82% | -80.74% | 4.11% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 831.31M | 831.31M | 750.65M | 102.26M | 111.31M |
| Weighted Avg Shares Out (Dil) | 831.31M | 831.31M | 750.65M | 102.26M | 111.31M |
Source: https://incomestatements.info
Category: Stock Reports